Hidradenitis Suppurativa Treatment Market Size, Share, Growth Analysis Report and Forecast Trends (2026-2035)

Hidradenitis Suppurativa Treatment Market: Introduction and Insights

Hidradenitis suppurativa (HS) is an autoinflammatory and non-contagious skin condition which targets the hair follicles, leading to recurring abscesses in sweaty areas of the body, which are painful as well. The body parts that can be affected include groin, axillary, perineal, perianal, and inframammary locations. While there is no cure for the condition yet, but the treatment can help relieve the symptoms and prevent further progression of the condition.

Hidradenitis suppurativa (HS), also known as acne inversa, is often diagnosed at a later stage because it is mostly confused with skin infection or severe acne. There is no known diagnostic method to detect this condition, so the patient becomes completely dependent on the dermatologist to diagnose the condition based on the medical history of the patient, symptoms, and the appearance of these lesions. HS also leads to other associated conditions like severe pain, drainage, sensitive skin, odour, and deep scarring. The most common condition where the doctor suggests the possibility of this condition is when the painful lesions are filled with pus and drainage.

It is a sensitive condition which requires proper treatment method customised especially for the patient based on their individual symptoms. The appearance of HS can differ from person to person. HS leads to the formation of skin growths like nodules, abscesses, or sinus tracts.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Hidradenitis Suppurativa Treatment Market Segmentations

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Epidemiology

The prevalence of the disease is low, possibly due to the lack of diagnostic facilities for this condition. This can also be attributed to the under-reporting and misdiagnosis of the condition owing to the lack of awareness about the condition. The disease is most likely to occur between the age of puberty to the age of around forty years, especially between the age of 21 to 29 years. Women are more vulnerable to this condition than men, there is a ratio of 3:1 between women and men.

Treatments and Therapies Used in the Global Hidradenitis Suppurativa Treatment Market

There are no cures for the disease yet, but the treatments can help in reducing inflammation and pain and heal the wounds. The available treatments can help in preventing the progression of the condition. 
The treatments currently available in the market include the following:

Skin Care- The first and foremost treatment that the dermatologist opts for the condition in the initial stages is skin care. Regular products available in the market might not help or even aggravate the condition even further. The dermatologist can make a skin care plan customized according to the condition and suggest products that can help in relieving inflammation and pain and these products are also useful in reducing the scarring. The most common addition to the skin care routine is a benzol peroxide facewash, followed by a gentle hydrating moisturizer, and over the top treatment gel. While other treatments might go on for some time, this is something that the patient has to follow throughout the condition to avoid recurrence of the condition.

Drugs or Medications- These drugs can be for be for oral consumption or topical application, depending on the severity of the HS. If the HS is mild and limit to a certain body part, then only topical medication is prescribed. If it is advanced and has spread throughout the body, then a combination of topical and oral medicines is used over a period of time. The most prominent drugs include NSAIDs, antibiotics, oral retinoids, corticosteroid, and hormone therapy, among others. These drugs must be used for the prescribed period of time only and not more due to their high potency.

Surgery- Severe HS is treated with punch debridement, surgical removal, incision and drainage, and issue-sparing excision with electrosurgery.

Other treatment options include in-clinic treatments like corticosteroid injection, laser surgery, botulinum toxin, incision and drainage, wide excision, deroofing, wound and pain care treatments, among others.

Competitive Landscape of the Hidradenitis Suppurativa Treatment Market

The report gives an in-depth analysis of the key players involved in the hidradenitis suppurativa treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• USB Biopharma

• Novartis International AG

• InflaRx GmbH

• Janssen Biotech, Inc.

• AbbVie Inc.

• Celgene Corp.

• ChemoCentryx Inc.

• Incyte Corporation

• Pfizer Inc.